Mustang Bio EPS MBIO
Diluted earnings per share by quarter and over the last twelve months, from 2015.
- Last 12 months, to Jun 30, 2026
- n/m
- a quarter missing
- Latest quarter, Q2 FY26
- −$0.16
- Fiscal year 2024
- −$46.03
Mustang Bio's twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.
In its latest quarter, Q2 FY26, it was −$0.16.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2024 | −$46.03 | n/a |
| FY2023 | −$307.50 | n/a |
| FY2022 | −$505.50 | n/a |
| FY2021 | −$570.00 | n/a |
| FY2020 | −$855.00 | n/a |
| FY2019 | −$967.50 | n/a |
| FY2018 | −$855.00 | n/a |
| FY2017 | −$922.50 | n/a |
| FY2016 | −$772.50 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.16 | n/a | n/a | |
| Q1 FY26 | −$0.14 | n/a | n/a | |
| Q3 FY25 | −$0.07 | n/a | −$1.21 | |
| Q2 FY25 | −$0.19 | n/a | −$3.10 | |
| Q1 FY25 | −$0.05 | n/a | −$21.27 | |
| Q4 FY24 | −$0.90 | n/a | −$46.03 | |
| Q3 FY24 | −$1.96 | n/a | −$88.13 | |
| Q2 FY24 | −$18.36 | n/a | −$147.67 | |
| Q1 FY24 | −$24.81 | n/a | −$229.31 | |
| Q4 FY23 | −$43.00 | n/a | −$307.50 | |
| Q3 FY23 | −$61.50 | n/a | −$388.50 | |
| Q2 FY23 | −$100.00 | n/a | −$448.00 |
Against its peers
Companies in Healthcare nearest Mustang Bio's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| MBIOMustang Bio | n/m | |
| OXBROXBRIDGE RE HOLDINGS | $0.02 | |
| EDUCEducational Development | $0.19 | |
| GTIMGood Times Restaurants | $0.21 | +75% a year |
| MDRRMedalist Diversified | $3.84 | |
| BCGBinah Capital | $0.16 | |
| VIPVulcan Infrastructure & Power | $0.07 | |
| MXCMexco Energy | $0.75 | −5% a year |
| CKXCKX Lands | $1.42 | +647% a year |
| MSGMMotorsport Games | $0.43 | +187% a year |
| ATCHAtlasClear | $0.01 | |
| Peer median | $0.20 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Mustang Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.